Anthropic’s $50,000 Claude-credit grant gets called out as useless for rare-disease research
96Stats · x · 2026-07-22
Anthropic’s $50,000 Claude-credit grants draw criticism from a rare-disease researcher
A researcher who works on rare cancers and AI-assisted detection for uncommon spinal diseases argues that Anthropic’s new up to $50,000 in Claude usage credits is not the same as real research funding.
Key points from the reply:
- For rare diseases, data scarcity is the main bottleneck, not model access.
- Claude is described as useful in general, but weak on rare-data analysis because such cases are underrepresented in training data.
- The commenter says they already work with hospitals in China that build specialized LLMs for rare diseases, which may be a better fit.
- They also criticize the U.S. government for proposed NIH budget cuts of roughly 40%, arguing that labs doing biology need real funding, not credits.
The post is essentially a reaction to Anthropic’s AI for Science initiative and its first focused call for rare-disease research.
More from Companies & People
- Chinese X post says Google is using Gemini speed and price to fight open models — xiaohu · 2026-07-22
- Circle says USDC has grown to about $77 billion as it pushes its own Arc L1 — srimisra · 2026-07-22
- OpenAI employee says inbox overload has made missing emails unavoidable — paw_lean · 2026-07-22
- YC founder says cloud coding agents fail on setup, not on the agent itself — Business_Teacher766 · 2026-07-22
- Poolside wins attention with monthly open-model releases and hands-on home deployment support — xeophon · 2026-07-22
- Sequoia’s Doug Leone says it hires people with “a shock in their system” — atShruti · 2026-07-22